Pekin Hardy Strauss Inc. boosted its position in The Cooper Companies, Inc. (NASDAQ:COO – Free Report) by 11.2% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 80,419 shares of the medical device company’s stock after purchasing an additional 8,124 shares during the quarter. Pekin Hardy Strauss Inc.’s holdings in Cooper Companies were worth $4,546,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Algert Global LLC bought a new position in Cooper Companies during the 2nd quarter worth $7,655,000. Bank of America Corp DE bought a new stake in shares of Cooper Companies in the second quarter valued at about $144,125,000. BlackRock Inc. bought a new stake in shares of Cooper Companies in the second quarter valued at about $1,077,762,000. National Pension Service boosted its position in shares of Cooper Companies by 9,314.0% in the second quarter. National Pension Service now owns 526,149 shares of the medical device company’s stock valued at $37,730,000 after acquiring an additional 520,560 shares during the period. Finally, Nykredit A S acquired a new position in shares of Cooper Companies in the second quarter valued at about $2,070,000. 24.39% of the stock is owned by institutional investors and hedge funds.
Cooper Companies Price Performance
Shares of NASDAQ COO opened at $63.51 on Friday. The business has a fifty day moving average price of $59.37 and a two-hundred day moving average price of $68.70. The stock has a market capitalization of $12.08 billion, a PE ratio of 21.68, a P/E/G ratio of 2.53 and a beta of 0.83. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.22 and a quick ratio of 0.73. The Cooper Companies, Inc. has a fifty-two week low of $51.01 and a fifty-two week high of $89.83.
Cooper Companies (NASDAQ:COO – Get Free Report) last released its earnings results on Wednesday, September 9th. The medical device company reported $1.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.12 by $0.03. The company had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.10 billion. Cooper Companies had a return on equity of 10.90% and a net margin of 13.46%. Cooper Companies’s quarterly revenue was up .5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.49 EPS. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. As a group, equities analysts predict that The Cooper Companies, Inc. will post 4.53 earnings per share for the current fiscal year.
Cooper Companies announced that its Board of Directors has authorized a share buyback program on Wednesday, September 9th that permits the company to repurchase $3 billion in outstanding shares. This buyback authorization permits the medical device company to reacquire up to 22.7% of its stock through open market purchases. Share buyback programs are often an indication that the company’s leadership believes its stock is undervalued.
Analysts Set New Price Targets
A number of research firms recently commented on COO. UBS Group lowered their price target on shares of Cooper Companies from $75.00 to $66.00 and set a “neutral” rating on the stock in a research report on Thursday, September 10th. Weiss Ratings downgraded shares of Cooper Companies from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, October 28th. Piper Sandler reissued a “neutral” rating on shares of Cooper Companies in a report on Thursday, October 15th. Barclays upgraded shares of Cooper Companies to a “hold” rating in a research report on Wednesday, October 7th. Finally, Zacks Research cut shares of Cooper Companies from a “hold” rating to a “strong sell” rating in a report on Friday, September 11th. Four analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $68.60.
Check Out Our Latest Research Report on Cooper Companies
Insider Activity at Cooper Companies
In other news, Director Lawrence Kurzius acquired 10,000 shares of Cooper Companies stock in a transaction on Monday, September 14th. The shares were purchased at an average cost of $53.91 per share, for a total transaction of $539,100.00. Following the completion of the purchase, the director directly owned 21,099 shares of the company’s stock, valued at approximately $1,137,447.09. This represents a 90.10% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Paul A. Keel bought 4,701 shares of the firm’s stock in a transaction on Friday, September 11th. The stock was purchased at an average cost of $53.18 per share, for a total transaction of $249,999.18. Following the completion of the acquisition, the director owned 4,701 shares in the company, valued at approximately $249,999.18. This trade represents a ∞ increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders purchased a total of 34,701 shares of company stock valued at $1,880,039 over the last quarter. 2.08% of the stock is owned by corporate insiders.
About Cooper Companies
CooperCompanies is a global medical device company that develops, manufactures and markets products for vision care and women’s health. The company operates through two primary business segments: CooperVision and CooperSurgical.
CooperVision provides contact lenses and related technologies, including products designed for myopia management, astigmatism, presbyopia and other vision-correction needs. Its portfolio includes daily disposable, reusable and specialty contact lenses sold through eye-care professionals and distributors.
CooperSurgical develops products and services for fertility and women’s health.
Featured Articles
- Five stocks we like better than Cooper Companies
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO – Free Report).
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.
